this study found that the sensitivity (67.7%) of plasma GM combined with IL-17 in diagnosing IPA in patients with non-neutropenic was significantly higher than that of plasma GM, while there was no significant difference in specificity (83.1%). The gene discussed is IL17A; the disease is Ito hypomelanosis.